Concepedia

Rob Howes

RH

Statistics

Publications

14

Citations

1.8K

H-Index

14

Active since

2004

Affiliations

Granta Design (United Kingdom)(Current)

Recombinant Antibody Technology (United Kingdom)

Rob Howes is an author at Granta Design (United Kingdom) specializing in pharmacology, drug discovery, and drug design.

Publications per year

2004–2018

14

Publications

14

NVP-AUY922: A Novel Heat Shock Protein 90 Inhibitor Active against Xenograft Tumor Growth, Angiogenesis, and Metastasis

Suzanne A. Eccles, Andy Massey, Florence I. Raynaud et al. · Cancer Research · 2008 · 478 citations · Full text

, , +8

Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening

Nicolas Foloppe, Lisa M. Fisher, Rob Howes et al. · Bioorganic & Medicinal Chemistry · 2006 · 363 citations · Full text

, , +14

Novel Adenosine-Derived Inhibitors of 70 kDa Heat Shock Protein, Discovered Through Structure-Based Design

D.S. Williamson, Jenifer Borgognoni, Alexandra Clay et al. · Journal of Medicinal Chemistry · 2009 · 229 citations · Full text

, , +14

Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)

Alexandra Grassian, Fallon Lin, Rosemary Barrett et al. · Journal of Biological Chemistry · 2012 · 140 citations · Full text

, , +17

Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity

Alba T. Macias, D.S. Williamson, Nicola J. Allen et al. · Journal of Medicinal Chemistry · 2011 · 114 citations · Full text

, , +15

1–5 of 14